About Softgel
Healthcare
Nearly two decades of
innovation, integrity, and speed-to-market,
delivering reliable softgel solutions to partners worldwide.
Not just a softgel CDMO, a partner in possibility
Who we are
Softgel Healthcare was built to solve a critical need in healthcare manufacturing: a partner that combines scientific rigor, regulatory confidence, and operational reliability, without compromising speed or trust.
For nearly two decades, we have specialized in the development and manufacturing of high-quality softgel dosage forms for pharmaceutical and nutraceutical partners around the world. From formulation design to commercial-scale production, our focus has always been clear: enable our partners to launch and scale products with confidence.
Group & Ownership
Today, Softgel Healthcare is owned/backed by Everstone Capital, a global investment firm with deep expertise in building long-term, value-driven businesses and operates as part of Madras Group, a diversified healthcare and pharmaceutical manufacturer.
This foundation gives us more than scale.
It gives us stability, governance, capital strength, and access to a broader ecosystem of technologies, talent, and infrastructure, all of which directly benefit our partners. Rooted in India and expanding across global markets, Softgel Healthcare is positioned not just as a manufacturer, but as a CDMO built for longevity, resilience, and global growth.
Our Impact in Numbers
years
of softgel manufacturing expertise
billion
capsules produced annually
stable
formulations
developed
markets
served
partners
across pharmaceuticals and nutraceuticals
2 manufacturing
units
built on world-class standards
What Drives Us
We believe that health moves forward when science and partnership come together.
Guided by integrity and operational excellence, we deliver solutions that are safe, effective, compliant, and scalable.
Scientific precision
Trusted quality
Agility and speed-to-market
Transparent, long-term partnerships
Innovation across formats and technologies
Global Vision & Expansion
As part of a larger healthcare manufacturing platform, Softgel Healthcare is actively expanding its global footprint to better serve partners where they operate.
In line with our long-term growth strategy, we are investing in a new, next-generation manufacturing facility designed to expand capacity, enhance technological capabilities, and meet the evolving regulatory and volume requirements of global pharmaceutical and nutraceutical markets.
This new site reinforces our commitment to operational resilience, supply continuity, and scalable growth, ensuring we can support partners not only today, but as their portfolios and markets expand.
Our presence in the Americas is further strengthened through PRODOSE, our U.S.-based OTC distribution and market access arm, enabling faster execution and closer proximity to customers. Together, this integrated model allows Softgel Healthcare to combine world-class manufacturing, geographic expansion, and market intelligence under one trusted platform.
How We Work
We operate with a partnership-first mindset.
From early-stage formulation development to large-scale commercial manufacturing, our teams collaborate closely with clients to ensure technical alignment, regulatory readiness, and supply reliability.
Our process
Supported by group-level capabilities and complemented by U.S. market access through PRODOSE, we offer partners not only manufacturing excellence, but a clearer path to commercialization.
We deliver more than capsules.
We deliver trust, consistency, and the confidence to grow.
Trusted by 100+ across 60+ countries
Delivering quality softgels worldwide
